BENATI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 3.328
EU - Europa 1.730
AS - Asia 582
OC - Oceania 26
SA - Sud America 6
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.675
Nazione #
US - Stati Uniti d'America 3.308
IT - Italia 574
GB - Regno Unito 442
CN - Cina 205
SE - Svezia 196
SG - Singapore 176
DE - Germania 150
HK - Hong Kong 121
UA - Ucraina 83
FR - Francia 82
FI - Finlandia 37
NL - Olanda 36
BG - Bulgaria 33
AU - Australia 26
TR - Turchia 23
IE - Irlanda 19
BE - Belgio 17
CA - Canada 16
LT - Lituania 13
CH - Svizzera 12
ID - Indonesia 10
CZ - Repubblica Ceca 9
IN - India 9
JP - Giappone 8
KR - Corea 8
VN - Vietnam 8
ES - Italia 7
RU - Federazione Russa 6
IR - Iran 5
TW - Taiwan 4
GR - Grecia 3
MY - Malesia 3
AL - Albania 2
AT - Austria 2
BZ - Belize 2
CO - Colombia 2
DK - Danimarca 2
MX - Messico 2
RO - Romania 2
UY - Uruguay 2
CL - Cile 1
EU - Europa 1
HR - Croazia 1
LV - Lettonia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
TH - Thailandia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 5.675
Città #
Fairfield 473
Southend 362
Chandler 261
Ashburn 254
Santa Clara 249
Woodbridge 217
Houston 196
Seattle 166
Nyköping 164
Wilmington 164
Cambridge 156
Singapore 153
Dearborn 148
Jacksonville 143
Hong Kong 114
Ann Arbor 89
Bologna 77
Modena 57
San Diego 50
Beijing 46
Princeton 40
Helsinki 34
Sofia 33
Eugene 31
New York 28
Milan 22
Munich 21
Falls Church 19
Shanghai 17
Bremen 16
Brussels 16
London 16
Queens 16
Izmir 15
Rome 15
Redwood City 14
Dublin 13
Paris 13
Parma 13
Boardman 12
Jakarta 10
Adelaide 9
Brno 9
Phoenix 9
Des Moines 8
Dong Ket 8
Hefei 8
Los Angeles 8
Napoli 8
San Jose 8
Trento 8
Canberra 7
Padova 7
Toronto 7
Wuhan 7
Amstelveen 6
Dallas 6
Guangzhou 6
Nanjing 6
Reggio Emilia 6
Amsterdam 5
Minerbio 5
Roncoferraro 5
Sydney 5
Vignola 5
Avigliano Umbro 4
Empoli 4
Fresno 4
Fuzhou 4
Gunzenhausen 4
Kunming 4
Palermo 4
Piacenza 4
San Francisco 4
Soave 4
Taipei 4
Tokyo 4
Trapani 4
Villejuif 4
Wimbledon 4
Zhengzhou 4
Acton 3
Ankara 3
Bari 3
Boskoop 3
Buffalo 3
Campagna Lupia 3
Casagiove 3
Castelfranco Emilia 3
Chiampo 3
Duderstadt 3
Florence 3
Formigine 3
Jinan 3
Jongno-gu 3
Limbiate 3
Madrid 3
Montréal 3
Naples 3
New Delhi 3
Totale 4.240
Nome #
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 297
CRISPR/Cas9-mediated specific knock-down of dominant mutations in Rhodopsin gene 270
CRISPR/Cas9 gene editing in vitro and in retinal cells in vivo 265
CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient 262
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 182
Altered Responses to Homeostatic Cytokines in Patients with Idiopathic CD4 Lymphocytopenia 180
An efficient in vitro transposition method by a transcriptionally regulated sleeping beauty system packaged into an integration defective lentiviral vector 173
DNA vaccination by electroporation amplifies broadly cross-restricted public TCR clonotypes shared with HIV Controllers 164
A High Frequency of HIV-Specific Circulating Follicular Helper T Cells Is Associated with Preserved Memory B Cell Responses in HIV Controllers 162
MHC Class II Tetramer Labeling of Human Primary CD4+ T Cells from HIV Infected Patients 161
CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers 158
Public T cell receptors confer high-avidity CD4 responses to HIV controllers 157
HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term 155
The shc family protein adaptor, Rai, negatively regulates T cell antigen receptor signaling by inhibiting ZAP-70 recruitment and activation 151
The strepsipteran endoparasite Xenos vesparum alters the immunocompetence of its host, the paper wasp Polistes dominulus 150
In vitro and in vivo CRISPR/Cas9-mediated genome editing to downregulate dominant mutations in Rhodopsin gene 144
Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases 142
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 136
Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus 135
Simvastatin impairs humoral and cell-mediated immunity in mice by inhibiting lymphocyte homing, T-cell activation and antigen cross-presentation 131
CRISPR/Cas9 Allele-Specific Design To Inactivate A Dominant-Negative Mutation In COL6A1 Causing Ullrich Muscular Dystrophy 128
Gene editing prospects for treating inherited retinal diseases 127
Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model 127
Bcr-Abl stabilizes β-catenin in chronic myeloid leukemia through its tyrosine phosphorylation 115
Comparison of the antigen sensitivity of Gag-specific CD4+ T cell responses in controlled HIV infection and HIV vaccination 113
SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of β-catenin and its nuclear signaling 112
SRC family kinases as potential therapeutic targets for malignancies and immunological disorders 112
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 110
Characterization of high avidity CD4+ T cells in HIV Controllers 107
Specific cTfh frequency correlates with memory B cell responses in HIV controllers. 106
Frequent sharing of high-affinity TCRs in naturally controlled HIV infection: implications for vaccination 92
HIV Controller CD4+ T cells preferentially express a public TCR clonotype that confers high avidity responses against Gag 90
T cell receptors from the HIV-specific repertoire, means for their production and therapeutic uses thereof 88
Molecular characterization of high avidity CD4+ T cells in HIV Controllers 82
Public TCRs confer high-avidity CD4 responses to HIV controllers 77
Specific Knock-down of P347S Dominant Mutation in Rhodopsin Gene by CRISPR/Cas9 System 75
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 73
Efficient CRISPR/Cas9-Mediated iIn Situ Correction of LAMB3 Gene in Keratinocytes Derived from Junctional Epidermolysis Bullosa Patient 64
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 61
Engineered Sleeping Beauty Transposon as Efficient System to Optimize Chimp Adenoviral Production 57
Erratum: Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases (European Journal of Immunology (2006) vol. 36 (11) 10.1002/eji.200636567)) 52
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 48
CRISPR/Cas9 allele-specifc design to inactivate a dominant-negative mutation in COL6A1 causing Ullrich muscular dystrophy. 45
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 39
Specific knock-down of C-terminal dominant mutation in Rhodopsin gene by CRISPR/Cas9 system 36
Induced Pluripotent Stem Cells and Genome-Editing Tools in Determining Gene Function and Therapy for Inherited Retinal Disorders 34
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 33
Totale 5.778
Categoria #
all - tutte 25.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020910 0 0 0 0 139 205 178 139 102 42 76 29
2020/2021847 114 23 78 64 74 62 54 110 43 104 83 38
2021/2022797 54 91 61 23 42 47 55 40 85 59 148 92
2022/20231.005 108 102 98 87 123 115 29 69 125 19 64 66
2023/2024671 32 53 55 64 94 30 48 85 20 32 59 99
2024/2025584 64 40 76 121 283 0 0 0 0 0 0 0
Totale 5.778